Geniposide, a natural inhibitor of UCP2, has been shown to ameliorate hepatic steatosis by blocking UCP2-mediated proton leakage and increasing the mitochondrial membrane potential and ATP synthesis. This evidence concerns the gene UCP2 and fatty liver disease.